More about

Multiple Myeloma

News
December 12, 2024
1 min read
Save

Urvi A. Shah, MD, receives award for groundbreaking dietary research in cancer at ASH

Urvi A. Shah, MD, received the David M. Goldenberg Clinical Research Training Institute Award at ASH Annual Meeting and Exposition.

News
December 08, 2024
3 min read
Save

Daratumumab superior to active monitoring for high-risk smoldering multiple myeloma

SAN DIEGO — Daratumumab monotherapy significantly delayed progression of high-risk smoldering multiple myeloma to active multiple myeloma compared with active monitoring, according to results of the randomized phase 3 AQUILA study.

News
December 07, 2024
4 min read
Save

High-fiber diet may slow progression of precursor conditions to multiple myeloma

SAN DIEGO — A high-fiber plant-based diet may delay progression of certain precursor conditions to multiple myeloma, according to study results presented at ASH Annual Meeting and Exposition.

News
November 19, 2024
5 min read
Save

Physician uses life’s challenges to ‘change things for the better’

Monique A. Hartley-Brown, MD, MMSc, turns life challenges into the desire and initiative to “change things for the better.”

News
November 14, 2024
1 min read
Save

Triplet regimen extends OS in relapsed or refractory multiple myeloma

A triplet regimen extended OS compared with the current standard of care for patients with relapsed or refractory multiple myeloma, according to a topline data announcement.

News
November 04, 2024
4 min read
Save

BRCA variants increase risk for multiple myeloma, particularly at younger age

Inherited variants in DNA repair genes such as BRCA1 and BRCA2 may increase risk for multiple myeloma, according to results of a retrospective study.

News
October 29, 2024
4 min watch
Save

VIDEO: High-fiber, plant-based diet improves metabolic factors in precancerous patients

ORLANDO — In patients with monoclonal gammopathy of undetermined significance and elevated BMI, a plant-based, high-fiber diet improved metabolic and microbiome profiles and immune subsets, according to a study.

News
October 29, 2024
2 min read
Save

Despite progress, disparities in HSCT utilization remain

Disparities in hematopoietic stem cell transplantation utilization for blood cancers have narrowed over time but still persist, according to study results.

View more